Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5+ DM) is a special subtype of dermatomyositis (DM), characterized by a high incidence of rapidly progressive interstitial lung disease (RPILD) and poor prognosis, making clinical management extremely challenging (1, 2). The gene discussed is IFIH1; the disease is dermatomyositis.